Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Moderna's Q4 earnings due Feb 14: analysts predict revenue decline & $2.73 loss. Explore vaccine demand, pipeline prospects, and stock outlook.

Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Marine Systems, a key segment for GD, continues to face margin pressure despite robust sales growth, as supply chain ...

NEW YORK - DraftKings Inc. (NASDAQ: DKNG) reported better-than-expected fourth quarter earnings on Thursday, sending its shares up 6% in after-hours trading. The online sports bet ...

Zoetis Inc (NYSE:ZTS). reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $1.40 compared to the forecasted $1.38. Despite the earnings ...